Pharma Industry Finland strongly supports the objectives of the proposed Biotech Act and recognizes its potential to strengthen the EUs competitiveness, attract investment, expand clinical research activity and accelerate patients access to innovative therapies. The Biotech Act offers an opportunity to reinforce Europes position as a competitive location for life sciences.
LKR
Lääketeollisuus ry / Pharma Industry Finland
Industry association · Finland · EU Transparency Register 135790630472-10
1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #1100 by legislative files engaged — a count of participation, not a measure of influence.
1.2
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2018
in the register since
Declares membership of
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade and business associations
- Registered as
- Lääketeollisuus ry
- Head office
- Helsinki, Finland
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Lääketeollisuus in PolicySpeak: request access →
Work at Lääketeollisuus ry / Pharma Industry Finland? so we know who speaks for it.
Their record over time
Lääketeollisuus ry / Pharma Industry Finland filed 1 position on 5 Aug 2026, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Lääketeollisuus ry / Pharma Industry Finland’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.